AKT1 and fatty liver disease: Conversely, AKT, a serine/threonine kinase downstream of the insulin receptor, regulates multiple metabolic processes including activation of de novo lipogenesis which, in turn, leads to triglyceride accumulation in hepatocytes, hepatic steatosis and a hypertriglyceridemia state [26].